2025-09-23 - Analysis Report
Okay, here's an analysis of Schrodinger Inc. (SDGR) based on the provided data.

**Report: Schrodinger Inc. (SDGR) Analysis**

**Company Overview:** Schrodinger Inc. is a company that develops software for computational drug discovery and materials science.

**1. Performance vs. S&P 500 (VOO)**

*   **SDGR Cumulative Return:** -53.89%
*   **VOO Cumulative Return:** 63.08%
*   **Disparity:** -115.5
*   **Relative Disparity:** 1.3 (Indicates SDGR's performance is near the bottom of its historical range relative to VOO)

**Analysis of Alpha/Beta and other Indicators (Multi Year):**

| Year       | CAGR     | MDD     | Alpha    | Beta   | Cap(B) |
| :----------- | :------- | :------- | :------- | :----- | :------- |
| 2020-2022  | -74.0% | 68.9% | -89.0% | -0.1 | 1.4 |
| 2021-2023  | -65.0% | 68.9% | -83.0% | -0.0 | 2.7 |
| 2022-2024  | 8.0% | 72.4% | -17.0% | -0.0 | 1.4 |
| 2023-2025  | 0.0% | 74.0% | -59.0% | -0.0 | 1.4 |

*   **CAGR:** Consistently negative for the earlier periods but shows improvement. The rate is not good.
*   **MDD:** High Maximum Drawdown values indicates high volatility and potential risk.
*   **Alpha:** Negative Alpha suggests underperformance relative to the market.
*   **Beta:** Low Beta suggests the stock is less sensitive to market movements
*   **Cap(B):** Stable Cap(B)

**2. Recent Price Action**

*   **Current Price:** $19.45
*   **Last Market Update:** Price: $19.72, Previous Close: $19.45, Change: +1.39% (Recent uptick)
*   **5-day Moving Average:** $19.14
*   **20-day Moving Average:** $19.26
*   **60-day Moving Average:** $20.18

The price is currently above the 5-day and 20-day moving averages but still below the 60-day moving average. The recent market update shows a positive change, potentially indicating a short-term upward trend.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.3367 (Low Risk)
*   **RSI:** 49.42 (Neutral)
*   **PPO:** 0.52 (Positive, but not strongly overbought)
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)" - Suggests a buy signal, but with caution due to the Market Risk Indicator
*   **Recent (20-day) Relative Disparity Change:** 1.3 (+) - Indicates a short-term upward trend.
*   **Expected Return:** -4456.2% (Very negative long-term outlook)
*   **Recent Price Change:** The price increased by 1.39%, indicating a recent upward movement, possibly triggered by a specific event or news.

**4. Recent News & Significant Events**

*   **[2025-09-18]** Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
*   **[2025-09-11]** Schrödinger (SDGR): Evaluating Valuation as Market Sentiment Remains Quiet (Simply Wall St.)
*   **[2025-09-09]** Does Schrodinger (SDGR) Have the Potential to Rally 40.43% as Wall Street Analysts Expect? (Zacks)
*   **[2025-08-27]** Schrödinger to Present at Morgan Stanley Global Healthcare Conference (Business Wire)
*   **[2025-08-14]** Schrödinger Announces Discontinuation of SGR-2921 Program (Business Wire)

The news is a mix of potentially positive (analyst expectations of a rally, conference presentation) and negative (discontinuation of a program). The inducement grants may have a short-term positive impact, but the program discontinuation raises concerns.

**4-2. Analyst Opinions**

*   **Consensus:** Neutral (no strong buy/sell signals)
*   **Target Price:**
    *   Average: $28.11
    *   High: $33.00
    *   Low: $19.00

Analysts, on average, see significant upside potential, but the low target price is near the current trading price, suggesting mixed sentiment.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
| :--------- | :---- | :-------- |
| 2025-08-06 | -0.59 | 0.05 B$ |
| 2025-05-07 | -0.82 | 0.06 B$ |
| 2024-11-12 | -0.52 | 0.04 B$ |
| 2024-07-31 | -0.74 | 0.05 B$ |
| 2025-08-06 | -0.74 | 0.05 B$ |

*   **EPS:** Consistently negative, indicating unprofitability.
*   **Revenue:** Relatively stable but low.

The company is not profitable, and revenue growth is not apparent in the provided data.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| :--------- | :------- | :-------------- |
| 2025-06-30 | $0.05B | 47.77%          |
| 2025-03-31 | $0.06B | 52.26%          |
| 2024-12-31 | $0.09B | 72.61%          |
| 2024-09-30 | $0.04B | 50.24%          |
| 2024-06-30 | $0.05B | 66.20%          |

**Capital and Profitability:**

| Quarter    | Equity | ROE        |
| :--------- | :------ | :--------- |
| 2025-06-30 | $0.34B | -12.59% |
| 2025-03-31 | $0.37B | -16.01%  |
| 2024-12-31 | $0.42B | -9.54%   |
| 2024-09-30 | $0.45B | -8.49%   |
| 2024-06-30 | $0.47B | -11.40%  |

*   **Revenue:** Fluctuating, with a recent slight decrease.
*   **Profit Margin:** High profit margins.
*   **Equity:** Decreasing over the period.
*   **ROE:** Consistently negative, reflecting the company's inability to generate profits from its equity.

**7. Overall Analysis & Summary**

Schrodinger (SDGR) is currently underperforming relative to the S&P 500, with a significant disparity in cumulative returns. While recent price action shows a short-term upward trend, the longer-term technical indicators and financial data paint a concerning picture. The company is not profitable, equity is decreasing, and long-term expected returns are extremely negative.

Analyst opinions are mixed, with an average target price above the current level but with considerable variance. Recent news events include both positive and negative developments.

**Recommendation:**

Based on the provided data, a cautious approach is warranted. While the recent price increase and analyst expectations of a potential rally might be tempting, the underlying financial performance and negative long-term outlook suggest significant risks. A more in-depth analysis is needed before considering a long-term investment.
